Pfizer Acquires Antibody Tech Firm
This article was originally published in The Pink Sheet Daily
Executive Summary
Pfizer has purchased all outstanding stock of California-based Bioren, a privately held company specializing in antibody optimization technology, Pfizer announced Aug. 15